Search research articles
Contact Us
Filters
Showing results (11-20 of 56) with videos related to
Page
of 6
Sort By:
Oncolytic Virotherapy
|
August 12, 2016
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)
Caroline J Breitbach, John C Bell, Tae-Ho Hwang, et al.
Vaccines
|
September 28, 2024
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
Mefotse Saha Cyrelle Ornella, Jae-Joon Kim, Euna Cho, et al.
Life Sciences
|
December 14, 2002
A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure
Tae-Ho Hwang, Byung-Cheol Yoon, Jin-Sook Jeong, et al.
Current Opinion in Virology
|
April 23, 2015
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic
Caroline J Breitbach, Kelley Parato, James Burke, et al.
European Journal of Gastroenterology & Hepatology
|
March 30, 2019
Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib
Young Mi Hong, Ki Tae Yoon, Tae Ho Hwang, et al.
Oncotarget
|
December 1, 2016
Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
Nam Hee Lee, Mikyung Kim, Sung Yong Oh, et al.
Korean Journal of Transplantation
|
June 30, 2022
Preoperative blood neutrophil count predicts survival in hepatocellular carcinoma patients with living donor liver transplantation
Young Mi Hong, Mong Cho, Ki Tae Yoon, et al.
Cancers
|
January 23, 2020
Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
S M Bakhtiar Ul Islam, Bora Lee, Fen Jiang, et al.
Journal of Korean Medical Science
|
October 16, 2002
Potential role of Homer-2a on cutaneous vascular anomaly
Jeong Tae Kim, Si Hyun Park, Soek Kwun Kim, et al.
European Journal of Gastroenterology & Hepatology
|
December 19, 2019
Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma
Young Mi Hong, Mong Cho, Ki Tae Yoon, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 56) with videos related to
Sort By:
Page
of 6
Oncolytic Virotherapy
|
August 12, 2016
The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)
Caroline J Breitbach, John C Bell, Tae-Ho Hwang, et al.
Vaccines
|
September 28, 2024
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
Mefotse Saha Cyrelle Ornella, Jae-Joon Kim, Euna Cho, et al.
Life Sciences
|
December 14, 2002
A single administration of adenoviral-mediated HGF cDNA permits survival of mice from acute hepatic failure
Tae-Ho Hwang, Byung-Cheol Yoon, Jin-Sook Jeong, et al.
Current Opinion in Virology
|
April 23, 2015
Pexa-Vec double agent engineered vaccinia: oncolytic and active immunotherapeutic
Caroline J Breitbach, Kelley Parato, James Burke, et al.
European Journal of Gastroenterology & Hepatology
|
March 30, 2019
Changes in the neutrophil-to-lymphocyte ratio predict the prognosis of patients with advanced hepatocellular carcinoma treated with sorafenib
Young Mi Hong, Ki Tae Yoon, Tae Ho Hwang, et al.
Oncotarget
|
December 1, 2016
Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
Nam Hee Lee, Mikyung Kim, Sung Yong Oh, et al.
Korean Journal of Transplantation
|
June 30, 2022
Preoperative blood neutrophil count predicts survival in hepatocellular carcinoma patients with living donor liver transplantation
Young Mi Hong, Mong Cho, Ki Tae Yoon, et al.
Cancers
|
January 23, 2020
Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
S M Bakhtiar Ul Islam, Bora Lee, Fen Jiang, et al.
Journal of Korean Medical Science
|
October 16, 2002
Potential role of Homer-2a on cutaneous vascular anomaly
Jeong Tae Kim, Si Hyun Park, Soek Kwun Kim, et al.
European Journal of Gastroenterology & Hepatology
|
December 19, 2019
Neutrophil-lymphocyte ratio predicts the therapeutic benefit of neoadjuvant transarterial chemoembolization in patients with resectable hepatocellular carcinoma
Young Mi Hong, Mong Cho, Ki Tae Yoon, et al.
Page
of 6